2m 2m 2m 2m 2m 2m 2m
Guided Therapeut (GTHP)
OTC
$0.23$0.00 (0.00%)
Price as of Jun 03, 2026- $22.1MMarket Cap
- 73.38%1-Year Change
- Medical DevicesIndustry
Guided Therapeut (GTHP)
$0.23$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 767,000 +10,857.14% | 7,000 -92.86% | 98,000 +653.85% | 13,000 -83.95% | |
Cost of Revenue | 196,000 +3,820.00% | 5,000 -91.94% | 62,000 -23.46% | 81,000 N/A | |
Gross Profit | 571,000 +28,450.00% | 2,000 -94.44% | 36,000 +152.94% | -68,000 -440.00% | |
Sales and Marketing Expense | 169,000 -41.11% | 287,000 +7.09% | 268,000 +48.07% | 181,000 +28.37% | |
Research and Development Expense | -469,000 -10.84% | -526,000 +130.70% | -228,000 +196.10% | -77,000 +11.59% | |
Depreciation and Amortization Expense | 10,000 +11.11% | 9,000 0.00% | 9,000 +125.00% | 4,000 +300.00% | |
Total Operating Expenses | 2.9M +39.48% | 2.1M -39.59% | 3.5M +6.98% | 3.3M +37.07% | |
Operating Profit | -2.4M +12.52% | -2.1M -39.02% | -3.5M +3.72% | -3.3M +41.11% | |
Interest Income | 0 -100.00% | 3,000 -50.00% | 6,000 N/A | N/A N/A | |
Interest Expense | -617,000 +61.94% | -381,000 +37.05% | -278,000 -52.23% | -582,000 -49.39% | |
Interest Income and Expense and Net | -617,000 +63.23% | -378,000 +38.97% | -272,000 -53.26% | -582,000 -49.39% | |
Total Nonoperating Income and Expense | -824,000 +166.67% | -309,000 +865.63% | -32,000 -96.83% | -1.0M -445.21% | |
Income before Taxes | -3.2M +32.23% | -2.4M -30.73% | -3.5M -19.63% | -4.3M +109.71% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -3.2M +32.23% | -2.4M -30.73% | -3.5M -19.63% | -4.3M +109.71% | |
Net Income from Continuing Operations Applicable to Common | -3.3M +29.14% | -2.6M -31.07% | -3.8M -24.40% | -5.0M +104.52% | |
Basic EPS and Net Income | -0.04 -20.00% | -0.05 -28.57% | -0.07 -53.33% | -0.15 -16.67% | |
Diluted EPS and Net Income | -0.04 -20.00% | -0.05 -28.57% | -0.07 -53.33% | -0.15 -16.67% | |
Basic Weighted Average Shares | 78.4M +36.76% | 57.3M +12.14% | 51.1M +57.30% | 32.5M +142.99% | |
Diluted Weighted Average Shares | 78.4M +36.76% | 57.3M +12.14% | 51.1M +57.30% | 32.5M +142.99% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 63,000 -83.76% | 388,000 -34.35% | 591,000 -74.45% | 2.3M +259.72% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 63,000 -83.76% | 388,000 -34.35% | 591,000 -74.45% | 2.3M +259.72% | |
Total Current Assets | 605,000 -49.46% | 1.2M -14.07% | 1.4M -53.63% | 3.0M +83.51% | |
Accumulated Depreciation | 1.6M +0.57% | 1.6M +0.57% | 1.6M -9.60% | 1.8M +0.17% | |
Property and Plant and Equipment and Net | 16,000 -30.43% | 23,000 -28.12% | 32,000 -23.81% | 42,000 +200.00% | |
Total Long-Term Assets | 719,000 +297.24% | 181,000 -34.42% | 276,000 -23.76% | 362,000 -10.17% | |
Total Assets | 1.3M -3.92% | 1.4M -17.44% | 1.7M -50.42% | 3.4M +65.00% | |
Income Taxes Payable | 1.7M +69.93% | 1.0M +4.23% | 970,000 -22.21% | 1.2M -29.47% | |
Total Short-Term Debt | 347,000 +30.17% | 266,583 N/A | 0 -100.00% | 18,000 -92.77% | |
Total Current Liabilities | 6.6M +7.81% | 6.2M +27.99% | 4.8M -1.23% | 4.9M -14.49% | |
Total Long-Term Debt | 23,000 -62.30% | 61,000 N/A | 0 -100.00% | 1.1M -21.27% | |
Total Long-Term Liabilities | 694,000 +519.64% | 112,000 -83.18% | 666,000 -51.74% | 1.4M -22.95% | |
Total Liabilities | 7.3M +16.96% | 6.3M +14.47% | 5.5M -12.39% | 6.2M -16.51% | |
Retained Earnings | -157.1M +2.18% | -153.7M +1.71% | -151.1M +2.55% | -147.4M +3.49% | |
Total Stockholders Equity | -6.0M +22.85% | -4.9M +28.46% | -3.8M +32.02% | -2.9M -47.05% | |
Total Shares Outstanding | 86.2M +32.28% | 65.1M +20.38% | 54.1M +11.34% | 48.6M +255.42% | |
Cash Flow | |||||
Cash from Operating Activities | -1.1M -4.56% | -1.1M -35.91% | -1.7M +18.13% | -1.5M -7.16% | |
Capital Expenditures | 2,000 N/A | N/A N/A | 0 -100.00% | 31,000 +121.43% | |
Cash from Investing Activities | -2,000 N/A | N/A N/A | N/A N/A | -31,000 +121.43% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 745,000 -18.67% | 916,000 +3,716.67% | 24,000 -99.25% | 3.2M +53.85% | |
Financials Ratio | |||||
Gross Margin | 74.45% +160.56% | 28.57% -22.22% | 36.73% +107.02% | -523.08% N/A | |
Operating Margin | -309.26% -98.97% | -30,114.29% +753.69% | -3,527.55% -86.24% | -25,638.46% +779.22% | |
Return on Assets | -236.57% +49.11% | -158.65% +14.47% | -138.59% -13.70% | -160.60% +31.51% | |
Return on Equity | 58.67% +5.53% | 55.60% -46.71% | 104.32% +0.07% | 104.25% +310.46% | |
Revenue Growth | 10,857.14% +11,792.31% | -92.86% -114.20% | 653.85% +878.85% | -83.95% +307.76% | |
Current Ratio | 0.09 -53.11% | 0.19 -32.86% | 0.29 -53.05% | 0.62 +114.61% | |
Cash Ratio | 0.010 -84.92% | 0.06 -48.74% | 0.12 -74.13% | 0.48 +320.73% | |
Debt-to-Equity Ratio | -0.06 -8.06% | -0.07 N/A | 0.00 +100.00% | -0.40 +28.70% | |
Debt-to-Assets Ratio | 0.28 +17.59% | 0.24 N/A | 0.00 -100.00% | 0.34 -58.69% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow